What Happened?
Allendale, NJ-based Lonza Appointed Julie Roden as Senior Director, Global Sales - Cell and Gene Therapy
About the Company
Following the closing of the Capsugel acquisition, Lonza is one of the world`s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. An integrated solutions provider serving the healthcare continuum, Lonza offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. In addition to drinking water sanitizers, nutraceuticals, antidandruff agents and other personal care ingredients, the company provides agricultural products, advanced coatings and composites and microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 50 major manufacturing and R&D facilities and nearly 14,000 full-time employees worldwide.
About the Person
Julie Roden is Senior Director, Global Sales - Cell and Gene Therapy at Lonza. Previously, Julie held various senior HR leadership roles in the industry.
Info Source
News
Short Profile